| Product Code: ETC200140 | Publication Date: Jul 2023 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 |
The Indonesia Nuclear Medicine Radioisotopes Market was estimated at USD 411 Million in 2025 and is projected to reach USD 543 Million by 2032, growing at a CAGR of 4.1% from 2026 to 2032. This growth trajectory is underpinned by the rising prevalence of chronic diseases, the expansion of healthcare infrastructure, and the growing acceptance of advanced diagnostic techniques among medical professionals and patients alike. As demand for innovative imaging solutions rises, Indonesias market is poised for significant transformation.
This graph highlights how the Indonesia Nuclear Medicine Radioisotopes Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -0.3% | Shift in healthcare funding priorities |
| 2022 | 4.6% | Rising demand for advanced diagnostics |
| 2023 | 5.6% | Increased investment in healthcare infrastructure |
| 2024 | 5.4% | Growth in private healthcare sector |
| 2025 | 5.0% | Expansion of research and development |
| 2026 | 5.0% | Technological advancements in imaging |
| 2027 | 5.1% | Growing awareness of preventive care |
| 2028 | 5.5% | Increase in aging population demographics |
| 2029 | 5.4% | Enhanced regulatory support for innovations |
| 2030 | 5.5% | growing downstream application demand |
| 2031 | 5.4% | Rising prevalence of chronic diseases |
| 2032 | 5.2% | Emergence of new treatment modalities |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
Indonesia's nuclear medicine landscape is characterized by a dual-source system for radioisotope supply: imports and domestic production at the Advanced Technology Centre in Bandung. This combination not only ensures the availability of essential radioisotopes but also positions Indonesia as a key player in the Southeast Asian region.
The demand for radioisotopes has surged in recent years, driven by advancements in nuclear imaging technology and a heightened awareness of health issues. Facilities specializing in nuclear medicine have been expanding, particularly in urban and rural areas, making these essential diagnostic services more accessible to the general population.
Despite the growth potential, the Indonesia Nuclear Medicine Radioisotopes Market faces notable restraints. The high costs associated with procuring and installing advanced imaging equipment remain a significant barrier, particularly for smaller healthcare providers. Additionally, stringent regulations related to the importation and licensing of radioactive substances can complicate the supply chain. Further, there exists a shortage of skilled professionals capable of safely operating the sophisticated machinery used in nuclear imaging, which poses a challenge to service expansion.
The market is witnessing a shift towards more advanced imaging techniques, such as PET/CT scans, which provide superior diagnostic accuracy compared to conventional methods. This transition is complemented by increased investments in research and development of radiopharmaceuticals, leading to the production of shorter-lived isotopes that pose lower radiation risks to patients. Additionally, the trend of incorporating automated pharmacy systems is enhancing efficiency in the production and distribution processes of radioisotopes.
Genuine growth opportunities lie in the enhancement of domestic production capacities to reduce reliance on imports. Investing in training programs for medical professionals will also bolster the workforce capable of operating sophisticated imaging technology. Furthermore, expanding nuclear medicine services into underserved rural areas can significantly increase market reach and accessibility. The development of partnerships between public and private sectors could also facilitate innovation and investment in new technologies.
The Indonesian government has been actively promoting healthcare infrastructure development, which includes initiatives to improve access to nuclear medicine services. Policies aimed at increasing investment in the healthcare sector have been enacted, coupled with programs designed to enhance public health awareness. Incentives for hospitals and clinics to adopt advanced imaging technologies and easier regulatory frameworks for importing radioisotopes are also part of government efforts to ensure a steady supply and improved service delivery in nuclear medicine.
Looking towards the future, the Indonesia Nuclear Medicine Radioisotopes Market is expected to evolve significantly from 2026 to 2032. The continued integration of advanced imaging technologies will drive demand for radioisotopes, while the aging demographic will further necessitate enhanced diagnostic services. Investments in production infrastructure and workforce training will play a crucial role in addressing existing challenges. Overall, the market's growth trajectory appears promising as Indonesia seeks to improve its healthcare outcomes through innovative nuclear medicine solutions.
Recent developments in the Indonesia Nuclear Medicine Radioisotopes Market have been marked by significant advancements in research collaborations aimed at enhancing domestic production capabilities. New policies encouraging public-private partnerships are being rolled out to drive innovation in imaging technologies. Additionally, healthcare facilities have been upgrading their equipment to accommodate new diagnostic modalities, ensuring they remain competitive in the rapidly evolving market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Nuclear Medicine Radioisotopes Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Indonesia Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Indonesia Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Indonesia requiring nuclear medicine procedures |
4.2.2 Growing investments in healthcare infrastructure and technology in the country |
4.2.3 Rising awareness and adoption of advanced medical treatments using nuclear medicine radioisotopes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for handling and storage of radioisotopes |
4.3.2 Limited availability of skilled professionals to administer nuclear medicine procedures |
4.3.3 High initial setup costs and maintenance expenses for nuclear medicine facilities |
5 Indonesia Nuclear Medicine Radioisotopes Market Trends |
6 Indonesia Nuclear Medicine Radioisotopes Market, By Types |
6.1 Indonesia Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2022-2032F |
6.1.4 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2022-2032F |
6.1.5 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2022-2032F |
6.1.6 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2022-2032F |
6.1.7 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2022-2032F |
6.1.8 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2022-2032F |
6.1.9 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.2 Indonesia Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.3 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2022-2032F |
6.2.4 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2022-2032F |
6.2.5 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2022-2032F |
6.2.6 Indonesia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
7 Indonesia Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Indonesia Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Indonesia Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Indonesia Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Average waiting time for nuclear medicine procedures in Indonesia |
8.2 Percentage of hospitals equipped with nuclear medicine facilities |
8.3 Number of research collaborations between Indonesian institutions and international partners in the field of nuclear medicine |
9 Indonesia Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Indonesia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Indonesia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Indonesia Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Indonesia Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here